The leading gene editing company in the UK, CRISPR Biotech Engineering finalist of the Great British Entrepreneur Awards

CRISPR Biotech Engineering (CBE), is an early-stage genome editing company that is 100% committed to using innovative CRISPR-Cas9 technology to improve human lives, develop transformative gene-based therapies and equip students, scientists and researchers with the knowledge to help them understand how this revolutionary technology can transform human life as we know it.

CBE has been shortlisted from a long list of nominations, for the Disruptor of the Year category in the Wales Finals of the Great British Entrepreneur Awards. Their success recognises to their Director, Martina Fabricci.

Founder of the Great British Entrepreneur Awards, Francesca James, said: “Given what we’ve seen over the past few months, the 2020 edition of the Great British Entrepreneur Awards is arguably the most important. Now, more than ever, it’s vital that we celebrate the achievements of the country’s entrepreneurs and their determination in the face of such adversity.

I want to send my congratulations to each and every single entrepreneur who has made it to the shortlist this year, and I wish them the very best of luck for the regional finals.


Attached Media


About CRISPR BIOTECH ENGINEERING

At CRISPR Biotech Engineering (CBE), we are an early-stage genome editing company that is 100% committed to using innovative CRISPR-Cas9 technology to improve human lives, develop transformative gene-based therapies and equip students, scientists and researchers with the knowledge to help them understand how this revolutionary technology can transform human life as we know it.